MAM
Marquette Asset Management Portfolio holdings
AUM
$597M
1-Year Return
14.22%
This Quarter Return
-4.8%
1 Year Return
+14.22%
3 Year Return
+53.31%
5 Year Return
+85.41%
10 Year Return
+179.97%
AUM
$320M
AUM Growth
-$31.7M
(-9%)
Cap. Flow
-$16M
Cap. Flow
% of AUM
-4.99%
Top 10 Holdings %
Top 10 Hldgs %
73.73%
Holding
420
New
50
Increased
30
Reduced
66
Closed
171
Top Buys
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
$3.38M |
| 2 |
SPDR S&P Kensho New Economies Composite ETF
KOMP
|
$2.34M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$2.11M |
| 4 |
Vanguard Mid-Cap ETF
VO
|
$2.05M |
| 5 |
Avantis International Small Cap Value ETF
AVDV
|
$1.24M |
Top Sells
| 1 |
Technology Select Sector SPDR Fund
XLK
|
$5.98M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$3.49M |
| 3 |
Avantis US Equity ETF
AVUS
|
$2.63M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
$2.54M |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
$2.12M |
Sector Composition
| 1 | Consumer Discretionary | 1.65% |
| 2 | Technology | 1.35% |
| 3 | Healthcare | 1.31% |
| 4 | Financials | 0.95% |
| 5 | Industrials | 0.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
APi Group
APG
$14.6B
| $40K | 0.01% |
4,500
| – | – |
|
152
Exxon Mobil
XOM
$479B
| $37K | 0.01% |
428
| – | – |
|
153
Ecolab
ECL
$78B
| $36K | 0.01% |
250
-3
| -1% | -$432 |
|
|
ORKA
154
Oruka Therapeutics, Inc. Common Stock
ORKA
$561M
| $36K | 0.01% |
1,443
| – | – |
|
155
Illinois Tool Works
ITW
$77.4B
| $35K | 0.01% |
193
-2
| -1% | -$363 |
|
156
Taylor Devices
TAYD
$155M
| $34K | 0.01% |
+3,304
| New | +$34K |
|
157
Walt Disney
DIS
$214B
| $33K | 0.01% |
350
-18
| -5% | -$1.7K |
|
158
CVS Health
CVS
$93.5B
| $32K | 0.01% |
335
-7
| -2% | -$669 |
|
159
Trane Technologies
TT
$91.9B
| $32K | 0.01% |
222
| – | – |
|
160
NextEra Energy, Inc.
NEE
$146B
| $31K | 0.01% |
400
| – | – |
|
161
Nucor
NUE
$33.3B
| $30K | 0.01% |
278
-4
| -1% | -$432 |
|
162
Abbott
ABT
$231B
| $29K | 0.01% |
300
-8
| -3% | -$773 |
|
163
Nuveen Preferred & Income Opportunities Fund
JPC
$2.62B
| $29K | 0.01% |
4,190
-917
| -18% | -$6.35K |
|
164
Lam Research
LRCX
$127B
| $27K | 0.01% |
750
| – | – |
|
165
Mondelez International
MDLZ
$78.8B
| $27K | 0.01% |
500
-12
| -2% | -$648 |
|
166
Principal Financial Group
PFG
$18.1B
| $27K | 0.01% |
368
| – | – |
|
167
Zoetis
ZTS
$67.9B
| $26K | 0.01% |
175
-4
| -2% | -$594 |
|
168
Nike
NKE
$111B
| $25K | 0.01% |
300
-6
| -2% | -$500 |
|
169
Boeing
BA
$174B
| $24K | 0.01% |
200
| – | – |
|
170
Goldman Sachs
GS
$227B
| $24K | 0.01% |
82
-2
| -2% | -$585 |
|
171
Novartis
NVS
$249B
| $24K | 0.01% |
317
-48
| -13% | -$3.63K |
|
172
United Parcel Service
UPS
$71.6B
| $24K | 0.01% |
148
-28
| -16% | -$4.54K |
|
173
Prudential Financial
PRU
$38.3B
| $21K | 0.01% |
241
-6
| -2% | -$523 |
|
174
AbbVie
ABBV
$376B
| $20K | 0.01% |
150
| – | – |
|
175
Diageo
DEO
$61B
| $20K | 0.01% |
118
-3
| -2% | -$508 |
|